560 related articles for article (PubMed ID: 19948615)
1. Pompe disease in infants: improving the prognosis by newborn screening and early treatment.
Chien YH; Lee NC; Thurberg BL; Chiang SC; Zhang XK; Keutzer J; Huang AC; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
Pediatrics; 2009 Dec; 124(6):e1116-25. PubMed ID: 19948615
[TBL] [Abstract][Full Text] [Related]
2. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
[TBL] [Abstract][Full Text] [Related]
3. Alglucosidase alfa: new drug. Pompe disease: a short-term benefit.
Prescrire Int; 2007 Dec; 16(92):240-1. PubMed ID: 18092404
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for Pompe disease: an update, 2011.
Burton BK
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
[TBL] [Abstract][Full Text] [Related]
5. Pompe disease: early diagnosis and early treatment make a difference.
Chien YH; Hwu WL; Lee NC
Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
[TBL] [Abstract][Full Text] [Related]
6. Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening.
Chien YH; Lee NC; Huang HJ; Thurberg BL; Tsai FJ; Hwu WL
J Pediatr; 2011 Jun; 158(6):1023-1027.e1. PubMed ID: 21232767
[TBL] [Abstract][Full Text] [Related]
7. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
Katzin LW; Amato AA
J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
[TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study.
Klinge L; Straub V; Neudorf U; Voit T
Neuropediatrics; 2005 Feb; 36(1):6-11. PubMed ID: 15776317
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.
Kishnani PS; Hwu WL; Mandel H; Nicolino M; Yong F; Corzo D;
J Pediatr; 2006 May; 148(5):671-676. PubMed ID: 16737883
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.
Chien YH; Lee NC; Chen CA; Tsai FJ; Tsai WH; Shieh JY; Huang HJ; Hsu WC; Tsai TH; Hwu WL
J Pediatr; 2015 Apr; 166(4):985-91.e1-2. PubMed ID: 25466677
[TBL] [Abstract][Full Text] [Related]
11. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program.
Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH
Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
13. Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening.
Rigter T; Weinreich SS; van El CG; de Vries JM; van Gelder CM; Güngör D; Reuser AJ; Hagemans ML; Cornel MC; van der Ploeg AT
Mol Genet Metab; 2012 Nov; 107(3):448-55. PubMed ID: 23040796
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease.
Chen LR; Chen CA; Chiu SN; Chien YH; Lee NC; Lin MT; Hwu WL; Wang JK; Wu MH
J Pediatr; 2009 Aug; 155(2):271-5.e2. PubMed ID: 19486996
[TBL] [Abstract][Full Text] [Related]
15. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients.
Müller-Felber W; Horvath R; Gempel K; Podskarbi T; Shin Y; Pongratz D; Walter MC; Baethmann M; Schlotter-Weigel B; Lochmüller H; Schoser B
Neuromuscul Disord; 2007 Oct; 17(9-10):698-706. PubMed ID: 17643989
[TBL] [Abstract][Full Text] [Related]
16. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
[TBL] [Abstract][Full Text] [Related]
17. Pompe disease: a neuromuscular disease with respiratory muscle involvement.
Mellies U; Lofaso F
Respir Med; 2009 Apr; 103(4):477-84. PubMed ID: 19131232
[TBL] [Abstract][Full Text] [Related]
18. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
Kishnani PS; Beckemeyer AA; Mendelsohn NJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
[TBL] [Abstract][Full Text] [Related]
19. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.
Kishnani PS; Corzo D; Nicolino M; Byrne B; Mandel H; Hwu WL; Leslie N; Levine J; Spencer C; McDonald M; Li J; Dumontier J; Halberthal M; Chien YH; Hopkin R; Vijayaraghavan S; Gruskin D; Bartholomew D; van der Ploeg A; Clancy JP; Parini R; Morin G; Beck M; De la Gastine GS; Jokic M; Thurberg B; Richards S; Bali D; Davison M; Worden MA; Chen YT; Wraith JE
Neurology; 2007 Jan; 68(2):99-109. PubMed ID: 17151339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
